John J. Stuart
- Hematology top 5%
- Platelet Disorders and Treatments 4
- Genetics top 5%
- Internal Medicine top 10%
- Oncology top 5%
- Cancer Treatment and Pharmacology 11
- Lung Cancer Research Studies 6
-
- Breast Cancer Treatment Studies 4
-
- Lung Cancer Treatments and Mutations 6
-
- Neuroendocrine Tumor Research Advances 6
-
- Lymphoma Diagnosis and Treatment 6
-
- Heparin-Induced Thrombocytopenia and Thrombosis 4
- Co-authors
- Frederick RichardsM. Robert CooperCharles L. SpurrDougľas R. WhiteHyman B. MussDon V. JacksonGary LipscombDavid H. Buss
- Cited by
- HematologyGeneticsInternal Medicine
- Journals
- Cancer (16 papers)Cancer Chemotherapy and Pharmacology (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
John J. Stuart
51 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Hematology 266
- Genetics 209
- Internal Medicine 63
- Oncology 457
- Cancer Research 147
Countries citing papers authored by John J. Stuart
This map shows the geographic impact of John J. Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Stuart more than expected).
Fields of papers citing papers by John J. Stuart
This network shows the impact of papers produced by John J. Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Stuart. The network helps show where John J. Stuart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John J. Stuart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 35 | |
| 2 | 1994 | 81 | |
| 3 | 1991 | 45 | |
| 4 | 1986 | 30 | |
| 5 | Rheological importance of acute-phase reactants. | 1986 | 2 |
| 6 | 1985 | 101 | |
| 7 | 1985 | 23 | |
| 8 | 1985 | 10 | |
| 9 | 1984 | 3 | |
| 10 | 1984 | 36 | |
| 11 | 1984 | 7 | |
| 12 | 1983 | 13 | |
| 13 | 1982 | 27 | |
| 14 | 1982 | 4 | |
| 15 | 1982 | 11 | |
| 16 | 1981 | 6 | |
| 17 | 1979 | 88 | |
| 18 | 1979 | 36 | |
| 19 | Thrombocytopenia in two patients treated with low-dose heparin. | 1978 | 18 |
| 20 | 1976 | 5 |
About John J. Stuart
John J. Stuart is a scholar working on Microbiology, Oncology and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Lung Cancer Treatments and Mutations (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Research Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Platelet Disorders and Treatments (4 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Hematology (266 citations), Genetics (209 citations) and Internal Medicine (63 citations). John J. Stuart has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Frederick Richards, M. Robert Cooper, Charles L. Spurr, Dougľas R. White, Hyman B. Muss, Don V. Jackson, Gary Lipscomb, David H. Buss, Christine A. Johnson and Robert Michielutte. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.